Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.74 M EUR
0.00 EUR
40.45 M
About TME PHARMA
Sector
Industry
CEO
Aram Andrew Mangasarian
Website
Headquarters
Berlin
Founded
2015
ISIN
NL0015000YE1
FIGI
BBG00DXBPNN7
TME Pharma NV is a clinical-stage biopharmaceutical company, which focuses on therapeutics targeting the tumor microenvironment or TME. The firm is active in pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Its pipeline includes NOX-A12 and NOX-E36. The company was founded on January 16, 2015 and is headquartered in Berlin, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALTME is 0.1470 EUR — it has decreased by −0.69% in the past 24 hours. Watch TME PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange TME PHARMA stocks are traded under the ticker ALTME.
ALTME stock has risen by 7.42% compared to the previous week, the month change is a 3.58% rise, over the last year TME PHARMA has showed a −59.46% decrease.
We've gathered analysts' opinions on TME PHARMA future price: according to them, ALTME price has a max estimate of 0.49 EUR and a min estimate of 0.49 EUR. Watch ALTME chart and read a more detailed TME PHARMA stock forecast: see what analysts think of TME PHARMA and suggest that you do with its stocks.
ALTME reached its all-time high on Mar 7, 2017 with the price of 1,994.2164 EUR, and its all-time low was 0.1124 EUR and was reached on Oct 16, 2024. View more price dynamics on ALTME chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALTME stock is 4.62% volatile and has beta coefficient of 0.41. Track TME PHARMA stock price on the chart and check out the list of the most volatile stocks — is TME PHARMA there?
Today TME PHARMA has the market capitalization of 6.10 M, it has decreased by −1.50% over the last week.
Yes, you can track TME PHARMA financials in yearly and quarterly reports right on TradingView.
TME PHARMA is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
No, ALTME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 13.00 employees. See our rating of the largest employees — is TME PHARMA on this list?
Like other stocks, ALTME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TME PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TME PHARMA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TME PHARMA stock shows the sell signal. See more of TME PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.